Results 1 -
10
of
23
for
Ibrutinib
- Ibrutinib is used to treat adults with chronic lymphocytic leukemia (CLL; a type of cancer that begins ... cancer that begins mostly in the lymph nodes). Ibrutinib is also used to treat adults with Waldenstrom's ...
- Acute Lymphocytic Leukemia/Statistics and Research ... Acute Lymphocytic Leukemia ... Acute Myeloid Leukemia/Statistics and Research ... Acute Myeloid Leukemia ... Childhood ...
- ... Several PLCG2 gene mutations have been associated with ibrutinib resistance, which is a condition in which the drug ibrutinib becomes ineffective in people with these mutations. Ibrutinib ...
- Lymphoma/Statistics and Research ... Lymphoma ... Hodgkin Lymphoma/Statistics and Research ... Hodgkin Lymphoma ... National Cancer Institute ... From the National Institutes ...
- Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, targeted therapy, and corticosteroids. Learn more about ...
- Lymphoma/Diagnosis and Tests ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Primary central nervous system (CNS) lymphoma treatment ...
- Lymphoma/Treatments and Therapies ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Primary central nervous system (CNS) lymphoma treatment ...
- ... activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of ... CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed ...
- Lymphoma/Diagnosis and Tests ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, ...
- Lymphoma/Start Here ... Lymphoma ... National Cancer Institute ... From the National Institutes of Health ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, ...